TRND
E421901
TRND is a National Institutes of Health program that accelerates the development of treatments for rare and neglected diseases by bridging the gap between basic research and clinical application.
All labels observed (1)
| Label | Occurrences |
|---|---|
| TRND canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T4210412 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: TRND Context triple: [Therapeutics for Rare and Neglected Diseases program, hasAbbreviation, TRND]
-
A.
TRA
TRA is the UK government body responsible for regulating the teaching profession, including overseeing teacher misconduct and maintaining professional standards.
-
B.
TRA
TRA is the ICAO airline designator assigned to Transavia, a Dutch low-cost carrier operating scheduled and charter flights across Europe and surrounding regions.
-
C.
TR
TR is the two-letter ISO 3166-1 alpha-2 country code assigned to Turkey for international standardization and referencing.
-
D.
TRN
TRN is the IATA airport code for Turin Airport, the main international airport serving Turin in northern Italy.
-
E.
TND
TND is the Tunisian dinar, the official currency of Tunisia.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: TRND Target entity description: TRND is a National Institutes of Health program that accelerates the development of treatments for rare and neglected diseases by bridging the gap between basic research and clinical application.
-
A.
TRA
TRA is the UK government body responsible for regulating the teaching profession, including overseeing teacher misconduct and maintaining professional standards.
-
B.
TRA
TRA is the ICAO airline designator assigned to Transavia, a Dutch low-cost carrier operating scheduled and charter flights across Europe and surrounding regions.
-
C.
TR
TR is the two-letter ISO 3166-1 alpha-2 country code assigned to Turkey for international standardization and referencing.
-
D.
TRN
TRN is the IATA airport code for Turin Airport, the main international airport serving Turin in northern Italy.
-
E.
TND
TND is the Tunisian dinar, the official currency of Tunisia.
- F. None of above. chosen
Statements (45)
| Predicate | Object |
|---|---|
| instanceOf |
NIH program
ⓘ
drug development program ⓘ translational research program ⓘ |
| abbreviationFor | Therapeutics for Rare and Neglected Diseases NERFINISHED ⓘ |
| approach |
collaborative project teams
ⓘ
public‑private partnerships ⓘ |
| collaboratesWith |
academic investigators
ⓘ
nonprofit organizations ⓘ small biotechnology companies ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| field |
drug development
ⓘ
neglected diseases ⓘ rare diseases ⓘ translational medicine ⓘ |
| focus |
early clinical development
ⓘ
preclinical development ⓘ |
| fullName | Therapeutics for Rare and Neglected Diseases ONNED1 ⓘ |
| fundingBody |
United States government
ⓘ
surface form:
U.S. federal government
|
| goal |
accelerate development of new treatments for rare and neglected diseases
ⓘ
bridge the gap between basic research and clinical application ⓘ |
| hasTypeOfTherapeutics |
biologics
ⓘ
repurposed drugs ⓘ small‑molecule drugs ⓘ |
| language | English ⓘ |
| mission | transform scientific discoveries into new treatments for patients with rare and neglected diseases ⓘ |
| operatedBy | National Institutes of Health ONNED1 ⓘ |
| parentOrganization | U.S. Department of Health and Human Services ONNED1 ⓘ |
| partOf | National Center for Advancing Translational Sciences NERFINISHED ⓘ |
| provides |
expertise in regulatory science
ⓘ
in‑kind drug development resources ⓘ project management for translational projects ⓘ |
| selectionCriteria |
feasibility of development
ⓘ
potential public health impact ⓘ scientific rationale ⓘ unmet medical need ⓘ |
| supports |
first‑in‑human clinical trials
ⓘ
formulation development ⓘ manufacturing scale‑up ⓘ preclinical efficacy studies ⓘ regulatory strategy and submissions ⓘ therapeutic candidate optimization ⓘ toxicology studies ⓘ |
| targetPopulation |
patients with neglected diseases
ⓘ
patients with rare diseases ⓘ |
| website | https://ncats.nih.gov/trnd ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: TRND Description of subject: TRND is a National Institutes of Health program that accelerates the development of treatments for rare and neglected diseases by bridging the gap between basic research and clinical application.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.